Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.

Boni C, Vecchi A, Rossi M, Laccabue D, Giuberti T, Alfieri A, Lampertico P, Grossi G, Facchetti F, Brunetto MR, Coco B, Cavallone D, Mangia A, Santoro R, Piazzolla V, Lau A, Gaggar A, Subramanian GM, Ferrari C.

Gastroenterology. 2018 May;154(6):1764-1777.e7. doi: 10.1053/j.gastro.2018.01.030. Epub 2018 Jan 31.

PMID:
29378197
2.

What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group.

Cuomo G, Borghi V, Giuberti T, Andreone P, Massari M, Villa E, Pietrangelo A, Verucchi G, Levantesi F, Ferrari C.

Infez Med. 2017 Jun 1;25(2):150-157.

3.

Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.

Fisicaro P, Barili V, Montanini B, Acerbi G, Ferracin M, Guerrieri F, Salerno D, Boni C, Massari M, Cavallo MC, Grossi G, Giuberti T, Lampertico P, Missale G, Levrero M, Ottonello S, Ferrari C.

Nat Med. 2017 Mar;23(3):327-336. doi: 10.1038/nm.4275. Epub 2017 Feb 6.

PMID:
28165481
4.

Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.

Boni C, Lampertico P, Talamona L, Giuberti T, Invernizzi F, Barili V, Fisicaro P, Rossi M, Cavallo MC, Vecchi A, Pedrazzi G, Alfieri A, Colombo M, Missale G, Ferrari C.

Hepatology. 2015 Dec;62(6):1697-709. doi: 10.1002/hep.28155. Epub 2015 Oct 29.

PMID:
26361374
5.

Nematocidal activity of extracellular enzymes produced by the nematophagous fungus Duddingtonia flagrans on cyathostomin infective larvae.

Braga FR, Soares FE, Giuberti TZ, Lopes Adel C, Lacerda T, Ayupe Tde H, Queiroz PV, Gouveia Ade S, Pinheiro L, Araújo AL, Queiroz JH, Araújo JV.

Vet Parasitol. 2015 Sep 15;212(3-4):214-8. doi: 10.1016/j.vetpar.2015.08.018. Epub 2015 Aug 20.

PMID:
26319197
6.

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

Fisicaro P, Valdatta C, Massari M, Loggi E, Ravanetti L, Urbani S, Giuberti T, Cavalli A, Vandelli C, Andreone P, Missale G, Ferrari C.

Gastroenterology. 2012 Dec;143(6):1576-1585.e4. doi: 10.1053/j.gastro.2012.08.041. Epub 2012 Aug 25.

PMID:
22929808
7.

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.

Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M; PegBeLiver Study Group.

Gut. 2013 Feb;62(2):290-8. doi: 10.1136/gutjnl-2011-301430. Epub 2012 Aug 2.

PMID:
22859496
8.

Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.

Boni C, Laccabue D, Lampertico P, Giuberti T, Viganò M, Schivazappa S, Alfieri A, Pesci M, Gaeta GB, Brancaccio G, Colombo M, Missale G, Ferrari C.

Gastroenterology. 2012 Oct;143(4):963-73.e9. doi: 10.1053/j.gastro.2012.07.014. Epub 2012 Jul 14.

PMID:
22796241
9.

Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis.

Penna A, Laccabue D, Libri I, Giuberti T, Schivazappa S, Alfieri A, Mori C, Canetti D, Lampertico P, Viganò M, Colombo M, Loggi E, Missale G, Ferrari C.

J Hepatol. 2012 Jun;56(6):1239-46. doi: 10.1016/j.jhep.2011.12.032. Epub 2012 Feb 9.

PMID:
22326467
10.

The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G.

Gastroenterology. 2008 May;134(5):1470-81. doi: 10.1053/j.gastro.2008.02.017. Epub 2008 Feb 14.

PMID:
18355815
11.

Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.

Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G, Bertoletti A, Ferrari C.

J Virol. 2007 Apr;81(8):4215-25. Epub 2007 Feb 7.

12.

Clinical spectrum of cryoglobulinaemic neuropathy.

Gemignani F, Brindani F, Alfieri S, Giuberti T, Allegri I, Ferrari C, Marbini A.

J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1410-4.

13.

Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response.

Pilli M, Penna A, Zerbini A, Vescovi P, Manfredi M, Negro F, Carrozzo M, Mori C, Giuberti T, Ferrari C, Missale G.

Hepatology. 2002 Dec;36(6):1446-52.

PMID:
12447871
14.

Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment.

Minelli R, Braverman LE, Giuberti T, Schianchi C, Gardini E, Salvi M, Fiaccadori F, Ugolotti G, Roti E.

Clin Endocrinol (Oxf). 1997 Sep;47(3):357-61.

PMID:
9373459
15.

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.

Roti E, Minelli R, Giuberti T, Marchelli S, Schianchi C, Gardini E, Salvi M, Fiaccadori F, Ugolotti G, Neri TM, Braverman LE.

Am J Med. 1996 Nov;101(5):482-7.

PMID:
8948271
16.

Lack of increased serum interleukin-6 and soluble IL-6 receptor concentrations in patients with thyroid diseases following recombinant human interferon alpha therapy.

Minelli R, Girasole G, Pedrazzoni M, Giuliani N, Schianchi C, Giuberti T, Braverman LE, Salvi M, Roti E.

J Investig Med. 1996 Aug;44(6):370-4.

PMID:
8795300
17.

Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.

Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A, Penna A, Giuberti T, Fiaccadori F, Ferrari C.

J Exp Med. 1994 Sep 1;180(3):933-43.

18.

Hepatitis C virus viremia following clinical resolution of acute hepatitis C.

Giuberti T, Marin MG, Ferrari C, Marchelli S, Schianchi C, Degli Antoni AM, Pizzocolo G, Fiaccadori F.

J Hepatol. 1994 May;20(5):666-71.

PMID:
7520923
19.

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections.

Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F.

Hepatology. 1994 Feb;19(2):286-95.

PMID:
8294086
20.

Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen.

Ferrari C, Cavalli A, Penna A, Valli A, Bertoletti A, Pedretti G, Pilli M, Vitali P, Neri TM, Giuberti T, et al.

Gastroenterology. 1992 Jul;103(1):255-63.

PMID:
1377142
21.

Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute nonA nonB hepatitis and different outcome of liver disease.

Giuberti T, Ferrari C, Marchelli S, Degli Antoni AM, Schianchi C, Pizzaferri P, Fiaccadori F.

Liver. 1992 Apr;12(2):94-9.

PMID:
1320178
22.

Immune pathogenesis of hepatitis B.

Ferrari C, Penna A, Bertoletti A, Cavalli A, Valli A, Missale G, Pilli M, Marchelli S, Giuberti T, Fiaccadori F.

Arch Virol Suppl. 1992;4:11-8. Review.

PMID:
1450676
23.

Prevalence of anti-HCV antibodies in patients with acute nonA-nonB viral hepatitis.

Giuberti T, Marchelli S, Degli Antoni A, Magnani G, Cavalli A, Pizzaferri P, Schianchi C, Ferrari C, Fiaccadori F.

Arch Virol Suppl. 1992;4:321-2.

PMID:
1333328
24.

Fine specificity of the human T cell response to hepatitis B virus core antigen.

Penna A, Bertoletti A, Cavalli A, Valli A, Missale G, Pilli M, Marchelli S, Giuberti T, Fowler P, Chisari FV, et al.

Arch Virol Suppl. 1992;4:23-8.

PMID:
1280506
25.

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.

Penna A, Chisari FV, Bertoletti A, Missale G, Fowler P, Giuberti T, Fiaccadori F, Ferrari C.

J Exp Med. 1991 Dec 1;174(6):1565-70.

26.

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.

Ferrari C, Bertoletti A, Penna A, Cavalli A, Valli A, Missale G, Pilli M, Fowler P, Giuberti T, Chisari FV, et al.

J Clin Invest. 1991 Jul;88(1):214-22.

27.

Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.

Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, Petit MA, Fiaccadori F.

J Immunol. 1990 Nov 15;145(10):3442-9.

PMID:
2230128
28.

Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B.

Ferrari C, Penna A, Giuberti T, Tong MJ, Ribera E, Fiaccadori F, Chisari FV.

J Immunol. 1987 Sep 15;139(6):2050-8.

PMID:
2957446
29.

Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B.

Ferrari C, Penna A, Sansoni P, Giuberti T, Neri TM, Chisari FV, Fiaccadori F.

Clin Exp Immunol. 1986 Dec;66(3):497-506.

31.

[Controlled protein administration diet and the prevention of hepatic encephalopathy].

Strata A, Giuberti T, Magnati G, Regolisti M, Sacchini D, Fiaccadori F.

Minerva Dietol Gastroenterol. 1984 Jul-Sep;30(3):245-50. Italian. No abstract available.

PMID:
6504373
32.

The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study.

Fiaccadori F, David S, Faggion G, Feriani N, Ferrari C, Franco V, Giuberti T, Grutta D'Auria C, La Greca G, Magnani G, et al.

Infection. 1984 Jan-Feb;12(1):23-6.

PMID:
6368400
33.

[Therapeutic effect of a new molecule, epomediol, in intrahepatic cholestasis].

Pasetti GC, De Simoni M, Giuberti T, Pedretti G, Pelosi G.

Clin Ter. 1982 May 31;101(4):371-86. Italian. No abstract available.

PMID:
7105642
34.

[Infectious agents in the G.I. tract diseases (author's transl)].

Magnani G, De Simoni M, Ferrari C, Giuberti T, Pedretti G, Sacchini D, Spadini G.

Ateneo Parmense Acta Biomed. 1980;51(4):311-21. Italian.

PMID:
6258609

Supplemental Content

Loading ...
Support Center